Sanfilippo syndrome type C
General Information (adopted from Orphanet):
Synonyms, Signs: |
MPS IIIC SANFILIPPO SYNDROME C MPS3C Mucopolysaccharidosis type 3C HGSNAT deficiency ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY Heparan-alpha-glucosaminide N-acetyltransferase deficiency |
Number of Symptoms | 49 |
OrphanetNr: | 79271 |
OMIM Id: |
252930
|
ICD-10: |
E76.2 |
UMLs: |
|
MeSH: |
|
MedDRA: |
|
Snomed: |
|
Prevalence, inheritance and age of onset:
Prevalence: | No data available. |
Inheritance: |
Autosomal recessive [Orphanet] |
Age of onset: |
|
Disease classification (adopted from Orphanet):
Parent Diseases: |
Mucopolysaccharidosis type 3
-Rare bone disease -Rare developmental defect during embryogenesis -Rare eye disease -Rare genetic disease -Rare neurologic disease |
Symptom Information:
|
(HPO:0002159) | Heparan sulfate excretion in urine | 12 / 7739 | ||||
|
(HPO:0000250) | Dense calvaria | 6 / 7739 | ||||
|
(HPO:0000280) | Coarse facial features | 189 / 7739 | ||||
|
(HPO:0000664) | Synophrys | 112 / 7739 | ||||
|
(HPO:0002788) | Recurrent upper respiratory tract infections | 31 / 7739 | ||||
|
(HPO:0000232) | Everted lower lip vermilion | 90 / 7739 | ||||
|
(HPO:0000268) | Dolichocephaly | 144 / 7739 | ||||
|
(HPO:0000510) | Rod-cone dystrophy | 266 / 7739 | ||||
|
(HPO:0000365) | Hearing impairment | 539 / 7739 | ||||
|
(HPO:0002371) | Loss of speech | 15 / 7739 | ||||
|
(HPO:0002360) | Sleep disturbance | 113 / 7739 | ||||
|
(HPO:0000752) | Hyperactivity | 140 / 7739 | ||||
|
(HPO:0001249) | Intellectual disability | 1089 / 7739 | ||||
|
(HPO:0001270) | Motor delay | 322 / 7739 | ||||
|
(HPO:0002333) | Motor deterioration | 7 / 7739 | ||||
|
(HPO:0002015) | Dysphagia | 301 / 7739 | ||||
|
(HPO:0001250) | Seizures | 1245 / 7739 | ||||
|
(HPO:0003309) | Ovoid thoracolumbar vertebrae | 6 / 7739 | ||||
|
(HPO:0000943) | Dysostosis multiplex | 22 / 7739 | ||||
|
(HPO:0000900) | Thickened ribs | 9 / 7739 | ||||
|
(HPO:0002751) | Kyphoscoliosis | 131 / 7739 | ||||
|
(HPO:0001387) | Joint stiffness | 322 / 7739 | ||||
|
(HPO:0001744) | Splenomegaly | 337 / 7739 | ||||
|
(HPO:0002240) | Hepatomegaly | 467 / 7739 | ||||
|
(HPO:0002014) | Diarrhea | 225 / 7739 | ||||
|
(HPO:0001507) | Growth abnormality | 36 / 7739 | ||||
|
(HPO:0001007) | Hirsutism | 91 / 7739 | ||||
|
(HPO:0002208) | Coarse hair | 58 / 7739 | ||||
|
(HPO:0001670) | Asymmetric septal hypertrophy | 19 / 7739 | ||||
|
(HPO:0003653) | Cellular metachromasia | 2 / 7739 | ||||
|
(HPO:0100790) | Hernia | 9 / 7739 | ||||
|
(OMIM) | Acetyl CoA:alpha-glucosaminidase N-acetyltransferase deficiency in fibroblasts | 1 / 7739 | ||||
|
(HPO:0003828) | Variable expressivity | 130 / 7739 | ||||
|
(OMIM) | Sleep disturbances common | 3 / 7739 | ||||
|
(OMIM) | Severe behavioral problems at age 3-4 | 2 / 7739 | ||||
|
(OMIM) | Enzyme replacement therapy has not been effective | 1 / 7739 | ||||
|
(OMIM) | Slowing mental development by 1.5 to 3 years of age | 3 / 7739 | ||||
|
(OMIM) | Mild splenomegaly | 6 / 7739 | ||||
|
(OMIM) | Clear cornea | 6 / 7739 | ||||
|
(OMIM) | Fleshy nasal tip | 1 / 7739 | ||||
|
(OMIM) | Coarse facies, mild | 3 / 7739 | ||||
|
(OMIM) | Thickening of the helices | 1 / 7739 | ||||
|
(OMIM) | Loss of speech development | 1 / 7739 | ||||
|
(OMIM) | Dysostosis multiplex, mild (in some patients) | 5 / 7739 | ||||
|
(OMIM) | Hepatomegaly, mild | 8 / 7739 | ||||
|
(OMIM) | Usually normal stature | 2 / 7739 | ||||
|
(OMIM) | Temper tantrums | 2 / 7739 | ||||
|
(OMIM) | Metachromasia of white blood cells and fibroblasts | 2 / 7739 | ||||
|
(HPO:0000007) | Autosomal recessive inheritance | 2538 / 7739 |
Associated genes:
ClinVar (via SNiPA)
Gene symbol | Variation | Clinical significance | Reference |
---|
Additional Information:
Description: (OMIM) |
Sanfilippo syndrome comprises several forms of lysosomal storage diseases due to impaired degradation of heparan sulfate. The deficient enzyme in Sanfilippo syndrome C, or MPS IIIC, is an acetyltransferase that catalyzes the conversion of alpha-glucosaminide residues to N-acetylglucosaminide ... |
Diagnosis OMIM |
Klein et al. (1981) described an assay for the detection in leukocytes of homozygous and heterozygous carriers of Sanfilippo syndrome type C. Affected individuals had no residual activity of acetyl-CoA:alpha-glucosaminide N-acetyltransferase. The authors noted that the enzyme was ... |
Clinical Description OMIM |
Kresse et al. (1976) reported 2 related patients of Greek origin with the phenotype of Sanfilippo syndrome who had normal values of heparan sulfamidase (605270) and alpha-N-acetylglucosaminidase (NAGLU; 609701). Metabolic correction was achieved upon cocultivation with Sanfilippo A ... |
Molecular genetics OMIM |
Fan et al. (2006) identified the HGSNAT gene (610453), encoding the human N-acetyltransferase, and identified 2 mutations accounting for 4 alleles in 2 human MPS IIIC cell lines. A splice junction mutation (610453.0001) accounted for 3 mutant alleles, ... |
Population genetics OMIM |
Using multiple ascertainment sources, Nelson et al. (2003) obtained an incidence rate for Sanfilippo syndrome (all forms combined) in western Australia for the period 1969 to 1996 of approximately 1 in 58,000 live births; there was a total ... |